Please assess the completion status of the following clinical trial:

Trial Title: Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* confirmed diagnosis of CF~* FEV1 greater than or equal to 75% of predicted normal for age, gender, and height~* oxyhemoglobin saturation greater than or equal to 90%~* clinically stable~Exclusion Criteria:~* abnormal renal or liver function~* clinically significant findings atypical for moderate cystic fibrosis

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).